Having established a paradigm whereby tumor-induced Irg1 in pResMφ results in fatty acid–mediated increases in ROS that in turn activate tumor cells in mice, we asked whether IRG1 expression might be detected in human ovarian cancers. This evidence concerns the gene ACOD1 and ovarian carcinoma.